SCHEMBL25459442

SCHEMBL25459442

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc(-c5cccc(-n6c7ccccc7c7cc8c9ccccc9n(-c9ccccc9)c8cc76)c5)nc4c3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPSE Q9Y251 9/20 0.45
▸ SMN1; SMN2 Q16637 6/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ NPC1 O15118 4/20 0.39
▸ RAB9A P51151 4/20 0.39
▸ CASP3 P42574 2/20 0.39
▸ SENP7 Q9BQF6 2/20 0.39
▸ SENP6 Q9GZR1 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459403 0.95 HPSE (0.48) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459466 0.94 HPSE (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459439 0.94 NPC1 (0.43) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459610 0.93 HPSE (0.46) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459455 0.92 HPSE (0.42) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459657 0.92 KDM4E (0.40) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25751763 0.92 HPSE (0.49) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL23079640 0.92 HPSE (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL23079743 0.92 HPSE (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10
SCHEMBL25459477 0.91 SMN1; SMN2 (0.47) HPSESMN1; SMN2KDM4EKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX HPSE 3938/4885SMN1; SMN2 4240/4885KDM4E 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback